Depression is a complex medical condition that affects how individuals think, feel, and function in daily life. For many patients, traditional treatment approaches such as antidepressant medications and psychotherapy provide meaningful relief. However, a significant portion of individuals continue to experience persistent symptoms despite multiple treatment attempts. For these patients, the impact on work, relationships, and overall quality of life can be profound.
Transcranial Magnetic Stimulation, commonly referred to as TMS, has emerged as an evidence-based, non-invasive treatment option for individuals with treatment-resistant depression. In Orange County, patients are increasingly seeking care models that combine clinical rigor, personalized treatment planning, and accessibility through insurance-based coverage. Understanding the TMS journey, from evaluation through outcomes, allows patients to make informed decisions grounded in both science and lived experience.
At Resiliency Mind + Body Medicine, TMS is delivered as part of an integrated psychiatric care model across two Orange County locations, providing patients with access to advanced neuromodulation in a supportive, medically supervised environment.
Understanding TMS for Depression
Transcranial Magnetic Stimulation is a non-invasive neuromodulation therapy that uses focused magnetic fields to stimulate regions of the brain involved in mood regulation. At Resiliency Mind + Body Medicine, treatment is delivered using BrainsWay Deep TMS, an FDA-cleared technology designed to reach broader and deeper brain networks implicated in major depressive disorder.
BrainsWay Deep TMS differs from earlier surface-level TMS systems by utilizing a specialized H-Coil, which allows magnetic stimulation to penetrate deeper cortical and subcortical structures associated with emotional processing. This expanded field of stimulation is intended to address the complex neural circuitry involved in depression rather than focusing on a single superficial region.
Like other forms of TMS, Deep TMS does not require anesthesia, sedation, or systemic medication exposure. Treatments are performed in an outpatient setting, and patients remain awake and alert throughout each session. BrainsWay Deep TMS is FDA-cleared for the treatment of major depressive disorder, including patients who have not responded adequately to antidepressant medications, with clinical outcomes supported by multiple peer-reviewed studies published in journals such as World Psychiatry and The Journal of Clinical Psychiatry.
Treatment Approach and Personalization
While TMS follows evidence-based protocols, effective outcomes depend on individualized planning and clinical oversight. At Resiliency Mind + Body Medicine, BrainsWay Deep TMS is incorporated into a comprehensive psychiatric treatment model that begins with a detailed diagnostic evaluation.
During the initial session, clinicians establish personalized stimulation parameters, including motor threshold measurements, to ensure accurate dosing and patient comfort. Deep TMS sessions are typically scheduled five days per week over several weeks, following FDA-cleared treatment protocols while allowing for clinical adjustments based on patient response.
Progress is monitored throughout the course of treatment using validated depression rating scales and ongoing provider assessments. This structured yet flexible approach allows care teams to tailor treatment intensity and support strategies, ensuring therapy remains aligned with each patient’s clinical presentation and goals.
The Patient Experience, Recovery, and Results
Each BrainsWay Deep TMS session lasts approximately 20 to 30 minutes. Patients are seated comfortably while the H-Coil helmet is positioned securely over the head. The sensation is commonly described as rhythmic tapping or pressure on the scalp, which most patients find manageable and become more familiar with over time.
Deep TMS does not require recovery time. Patients can drive themselves to and from appointments and resume normal daily activities immediately following treatment. This makes it a practical option for individuals balancing work, family responsibilities, and ongoing therapy.
Clinical studies of BrainsWay Deep TMS have demonstrated significant symptom reduction and remission rates in patients with treatment-resistant depression. Peer-reviewed research has shown that these improvements can be sustained over time, particularly when TMS is integrated into a broader mental health care plan that includes psychiatric follow-up and supportive therapy. As with all depression treatments, individual response varies, and outcomes are discussed transparently during the consultation process.
Determining Candidacy for BrainsWay Deep TMS
BrainsWay Deep TMS is intended for adults diagnosed with major depressive disorder who have not achieved sufficient symptom relief from antidepressant medications. It may also be appropriate for patients who are unable to tolerate medication side effects or who prefer a non-systemic treatment option.
Certain medical conditions may preclude candidacy, including a history of seizures, specific neurological disorders, or the presence of implanted metallic or electronic devices near the head. These considerations are carefully reviewed during a comprehensive evaluation to ensure patient safety and appropriateness.
Equally important is a patient’s ability to commit to the treatment schedule. Deep TMS requires consistent attendance over several weeks to achieve optimal results. At Resiliency Mind + Body Medicine, candidacy decisions are made collaboratively, with an emphasis on clinical appropriateness, safety, and long-term treatment success.
Taking the Next Step
For individuals experiencing depression that has not responded to traditional treatment approaches, BrainsWay Deep TMS offers an FDA-cleared, non-invasive option grounded in neuroscience and supported by clinical research. When delivered within a comprehensive psychiatric care model, Deep TMS can play a meaningful role in improving mood, cognitive function, and overall quality of life.
Resiliency Mind + Body Medicine offers BrainsWay Deep TMS at two Orange County locations, providing accessible, insurance-based care for patients seeking advanced depression treatment. The practice accepts most major insurance plans, helping reduce financial barriers and streamline the path to care.
A consultation allows patients to determine whether Deep TMS is an appropriate option and to receive personalized guidance based on their treatment history and goals.
